| 000 | 01641 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516101110.0 | ||
| 264 | 0 | _c20121221 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2012.06.035 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTafaghodi, Mohsen | |
| 245 | 0 | 0 |
_aHepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics. _h[electronic resource] |
| 260 |
_bVaccine _cAug 2012 |
||
| 300 |
_a5341-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Differentiation _ximmunology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 |
_aChitosan _xchemistry |
| 650 | 0 | 4 |
_aDendritic Cells _xcytology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B Antibodies _ximmunology |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xchemistry |
| 650 | 0 | 4 |
_aHepatitis B Vaccines _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNanoconjugates _xadministration & dosage |
| 700 | 1 | _aSaluja, Vinay | |
| 700 | 1 | _aKersten, Gideon F A | |
| 700 | 1 | _aKraan, Heleen | |
| 700 | 1 | _aSlütter, Bram | |
| 700 | 1 | _aAmorij, Jean-Pierre | |
| 700 | 1 | _aJiskoot, Wim | |
| 773 | 0 |
_tVaccine _gvol. 30 _gno. 36 _gp. 5341-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2012.06.035 _zAvailable from publisher's website |
| 999 |
_c21909344 _d21909344 |
||